Clinical Trials Directory

Trials / Terminated

TerminatedNCT01117376

Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients

Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients Intolerant to Enteral Feeding

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
42 (estimated)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

42 patients admitted in ICU with intolerance to enteral feeding (GRV more than 250 ml) are recruited. All patients enter a primary acetaminophen absorption test study as baseline. Serum levels of acetaminophen will be measured by florescence polarization method at 15,30,45,60,90,120,180,240,480 minutes after enteral administration of 975 mg acetaminophen. Then the patients will be randomized to methylnaltrexone or erythromycin group.Another acetaminophen absorption test with the same schedule will be done after the last dose of each drug.The area under the curve for acetaminophen blood level will be used to compare the effect of two studied drugs on gastric emptying time.

Conditions

Interventions

TypeNameDescription
DRUGErythromycinErythromycin 250 mg intravenous Q6h for 4 doses
DRUGMethylnaltrexoneMethylnaltrexone 12 mg subcutaneous Q12h for 2 doses

Timeline

Start date
2010-05-01
Primary completion
2011-06-01
Completion
2011-08-01
First posted
2010-05-05
Last updated
2011-03-31

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01117376. Inclusion in this directory is not an endorsement.